Canadian Health Officials Express Concerns Over New Nicotine Product

Regulations by 2FIRSTS.ai
Apr.22.2024
Canadian Health Officials Express Concerns Over New Nicotine Product
New health officer in Sudbury, Canada comments on risks of new nicotine products, highlighting concerns for youth exposure.

The Canadian newspaper "Niagara Falls Review" reported on April 21 that the new Chief Medical Officer of Health for Sudbury and district public health, Mustafa Hirji, shared his views on the risks of a new type of smoking cessation product. The health unit in Sudbury is working to ensure that the new nicotine products are kept away from children and teenagers.

 

Last year, the Canadian health department approved the sale of nicotine pouches in various stores including gas stations and convenience stores. These pouches are small and easy to consume, allowing users to place them between their teeth and cheeks to help quit smoking.

 

In response, Hillge stated, "This is a new innovation in the tobacco industry and a new method of delivering nicotine."

 

In July of last year, Zonnic, a nicotine pouch manufactured by Imperial Tobacco Company, was approved for sale in Canada. Hillwood pointed out that current regulations are too lenient, making nicotine pouches easily accessible to children who may be drawn to the stimulating effects of nicotine and potentially turn to smoking and e-cigarettes. Furthermore, despite warnings on the packaging of nicotine pouches, health officials are concerned that these products may still end up in the hands of teenagers.

 

He further explained that, despite these nicotine pouches not containing tobacco, it does not mean they do not have harmful effects on children. "Nicotine is harmful," he added, "it affects people's thinking, emotions, and attention, especially for adolescents, it can alter their brain structure in adulthood."

 

The health organization hopes to see nicotine pouches licensed as a medicine for adult use only, and to establish a policy to ensure that any future nicotine products are automatically treated equally. On Thursday, the full committee unanimously passed a motion reflecting these concerns and conveyed it to officials in Ottawa and Queen's Park.

 

A report is calling on the Canadian Ministry of Health to "take immediate action to close regulatory loopholes that allow the sale of nicotine pouches to individuals under the age of 18." Additionally, it is urging the Ontario government to "exclusively sell nicotine pouches in pharmacies, restrict their display in retail environments, and limit their promotion to youth," as well as expand the "Smoke-Free Ontario Strategy" and "develop a comprehensive, coherent regulatory framework for e-cigarettes and all nicotine-containing products that is public health-focused.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

BAT Confirms Vuse Marketing Success in H2, Federal Crackdown Key Driver
BAT Confirms Vuse Marketing Success in H2, Federal Crackdown Key Driver
BAT confirms significant improvement in Vuse's performance, attributing it to federal crackdown on illegal competitors, creating a unique market opportunity.
Dec.09 by 2FIRSTS.ai
China’s E-Cigarette Exports USD 1.096 billion in November, UK and South Korea Offset U.S. Decline
China’s E-Cigarette Exports USD 1.096 billion in November, UK and South Korea Offset U.S. Decline
China’s e-cigarette exports edged lower in November 2025, totaling USD 1.096 billion, down 0.2% month-on-month, as a decline in shipments to the United States was partially offset by stronger demand from the United Kingdom, Germany and South Korea, according to data released by the General Administration of Customs of China.
Dec.22 by 2FIRSTS.ai
Philip Morris International: Over $20 Billion Invested in the U.S. Since 2022; IQOS ILUMA to Launch Pending FDA Authorization
Philip Morris International: Over $20 Billion Invested in the U.S. Since 2022; IQOS ILUMA to Launch Pending FDA Authorization
Philip Morris International (PMI) said its U.S.-related investments have topped $20 billion since 2022, when it entered the U.S. market through its roughly $19 billion acquisition of Swedish Match. The company also said it plans to launch its heated tobacco product IQOS ILUMA in the United States pending authorization from the U.S. Food and Drug Administration (FDA).
Jan.16 by 2FIRSTS.ai
U.S. Court Rules Zyn Marketing Dispute Can Proceed, Rejects Philip Morris International’s Bid to Dismiss
U.S. Court Rules Zyn Marketing Dispute Can Proceed, Rejects Philip Morris International’s Bid to Dismiss
A U.S. federal court in Florida denied Philip Morris International and its subsidiaries’ motion to dismiss, allowing consumers to proceed with claims under the Florida Deceptive and Unfair Trade Practices Act alleging that Zyn nicotine pouches’ “tobacco-free” marketing is misleading. The court held that the allegations do not amount to a fraud claim and may move forward to the merits stage.
Dec.15 by 2FIRSTS.ai
Belgium: BAT plans to cut 51 jobs at Groot-Bijgaarden site
Belgium: BAT plans to cut 51 jobs at Groot-Bijgaarden site
British American Tobacco (BAT) has announced plans to cut 51 jobs at its Groot-Bijgaarden facility in Belgium, disclosed during a special works council meeting.
Jan.15 by 2FIRSTS.ai
Malaysia’s vape industry flags “policy U-turn” concerns after ban on refillable open-system e-cigarettes
Malaysia’s vape industry flags “policy U-turn” concerns after ban on refillable open-system e-cigarettes
Malaysia’s vape industry has raised concerns over the government’s decision to ban refillable open-system e-cigarettes, describing it as a policy reversal despite earlier regulatory approvals.
Jan.08 by 2FIRSTS.ai